| Prostate Cancer and PSA: Examining the role of mediation in the associations of individual characteristics with prostate specific antigen (PSA) and prostate cancer risk |
Sean Harrison |
University of Bristol |
PLCO |
Sep 8, 2015 |
PLCO-152 |
| Melanoma |
Gaston Liberman |
UTN FRBA |
PLCO |
Aug 25, 2015 |
PLCO-151 |
| DRE and prostate cancer detection in the PLCO cancer screening trial |
Jonathan Shoag |
NA |
PLCO |
Aug 24, 2015 |
PLCO-150 |
| Patterns of Care and Outcomes for Prostate Cancer in the United States |
Paul Nguyen |
Brigham and Women's Hospital |
PLCO |
Aug 17, 2015 |
PLCO-149 |
| History of lethal prostate cancer in the screening arm of PLCO |
Jonathan Shoag |
NA |
PLCO |
Aug 7, 2015 |
PLCO-147 |
| Lung Cancer Risk Factor Simulator |
Summer Han |
Stanford University |
PLCO |
Aug 3, 2015 |
PLCO-146 |
| Meta-analysis of risk factors for endometrial cancer in black women |
Lauren A. Wise |
Boston University School of Public Health |
PLCO |
Jul 6, 2015 |
PLCO-145 |
| Alcohol intake and risk of cancer and overall and cause-specific mortality |
Sonja Berndt |
National Cancer Institute |
PLCO |
Jun 12, 2015 |
PLCO-143 |
| Vasectomy and prostate cancer risk |
Jonathan Shoag |
NA |
PLCO |
Jun 2, 2015 |
PLCO-144 |
| Risk-stratified prostate cancer screening: Development of a risk score for informed decision-making and preventing overdiagnosis in primary health care |
Tobias Erlanger |
Berne Institute for Primary Health Care |
PLCO |
May 19, 2015 |
PLCO-142 |
| An analysis of the association between genetic variants and mitochondrial DNA copy number. |
Sonja Berndt |
NCI |
PLCO |
Apr 3, 2015 |
PLCO-140 |
| Lifestyle factors and health history among cancer survivors |
Mia Hashibe |
University of Utah |
PLCO |
Mar 23, 2015 |
PLCO-137 |
| Validation study of associations of medical conditions with subtypes of non-Hodgkin lymphoma |
Eric Engels |
NCI |
PLCO |
Mar 19, 2015 |
PLCO-138 |
| Longitudinal Prostate cancer prediction |
Jonathan Gelfond |
UT Health Science Center |
PLCO |
Mar 16, 2015 |
PLCO-135 |
| Pre- and Post-diagnostic NSAID Use and Prostate Cancer Mortality among Prostate Cancer Cases |
Michael Cook |
HREB/DCEG/NCI |
PLCO |
Mar 13, 2015 |
PLCO-136 |
| Association between Genetic Variation and Gall Bladder Stones and Inflammation |
Jill Koshiol |
NCI |
PLCO |
Mar 11, 2015 |
PLCO-134 |
| Epigenetic markers of multiple myeloma risk in peripheral blood DNA |
Kathryn Barry |
University of Maryland School of Medicine |
PLCO |
Mar 9, 2015 |
2015-0058 |
| Serum inflammation markers and esophageal adenocarcinoma risk |
Michael Cook |
DCEG - Other |
PLCO |
Mar 9, 2015 |
2015-0056 |
| Serum Levels of Autoantibodies and the Risk of Non-Hodgkin Lymphoma and Multiple Myeloma |
Jonathan Hofmann |
DCEG - Other |
PLCO |
Mar 9, 2015 |
2015-0051 |
| Pooled analysis of prospective cohort studies: the association between sex steroid hormones and esophageal/gastric cardia adenocarcinoma incidence |
Jessica Petrick |
NCI, DCEG, HREB |
PLCO |
Mar 9, 2015 |
2015-0040 |
